Docusign (NASDAQ:DOCU) CEO Allan Thygesen Sells 40,000 Shares

Docusign Inc. (NASDAQ:DOCU) CEO Allan Thygesen sold 40,000 shares of the company’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $69.69, for a total value of $2,787,600.00. Following the sale, the chief executive officer owned 136,246 shares in the company, valued at approximately $9,494,983.74. The trade was a 22.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Docusign Price Performance

Shares of Docusign stock opened at $69.73 on Friday. The stock’s 50-day moving average is $76.17 and its 200 day moving average is $79.04. The firm has a market cap of $14.02 billion, a price-to-earnings ratio of 52.43, a PEG ratio of 3.47 and a beta of 1.02. Docusign Inc. has a one year low of $62.66 and a one year high of $107.86.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, sell-side analysts expect that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Hedge Funds Weigh In On Docusign

Several institutional investors and hedge funds have recently bought and sold shares of the company. Aaron Wealth Advisors LLC grew its holdings in Docusign by 174.2% during the third quarter. Aaron Wealth Advisors LLC now owns 14,099 shares of the company’s stock valued at $1,016,000 after purchasing an additional 8,957 shares during the period. Corient Private Wealth LLC grew its holdings in Docusign by 23.6% during the second quarter. Corient Private Wealth LLC now owns 27,937 shares of the company’s stock valued at $2,176,000 after purchasing an additional 5,333 shares during the period. WT Wealth Management bought a new position in Docusign during the second quarter valued at $1,615,000. Centaurus Financial Inc. grew its holdings in Docusign by 2.6% during the second quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after purchasing an additional 136 shares during the period. Finally, Orion Porfolio Solutions LLC grew its holdings in Docusign by 50.8% during the second quarter. Orion Porfolio Solutions LLC now owns 23,832 shares of the company’s stock valued at $1,856,000 after purchasing an additional 8,031 shares during the period. 77.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DOCU shares. Argus reiterated a “hold” rating on shares of Docusign in a report on Monday, September 8th. Evercore ISI increased their price target on Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a report on Friday, September 5th. Wells Fargo & Company increased their price target on Docusign from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Friday, September 5th. UBS Group set a $95.00 price objective on Docusign in a research note on Friday, September 5th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a research note on Saturday, September 27th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have given a Hold rating to the company. According to data from MarketBeat, Docusign currently has a consensus rating of “Hold” and an average price target of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.